These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32070865)

  • 61. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment.
    Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM
    Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cationic nanoparticles self-assembled from amphiphilic chitosan derivatives containing poly(amidoamine) dendrons and deoxycholic acid as a vector for co-delivery of doxorubicin and gene.
    Chen S; Deng J; Zhang LM
    Carbohydr Polym; 2021 Apr; 258():117706. PubMed ID: 33593576
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging.
    Xie M; Shi H; Li Z; Shen H; Ma K; Li B; Shen S; Jin Y
    Colloids Surf B Biointerfaces; 2013 Oct; 110():138-47. PubMed ID: 23711784
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bone-Targeting Prodrug Mesoporous Silica-Based Nanoreactor with Reactive Oxygen Species Burst for Enhanced Chemotherapy.
    Tong F; Ye Y; Chen B; Gao J; Liu L; Ou J; van Hest JCM; Liu S; Peng F; Tu Y
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34630-34642. PubMed ID: 32635715
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
    Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
    Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Voltage/pH-Driven Mechanized Silica Nanoparticles for the Multimodal Controlled Release of Drugs.
    Wang T; Sun G; Wang M; Zhou B; Fu J
    ACS Appl Mater Interfaces; 2015 Sep; 7(38):21295-304. PubMed ID: 26345470
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drug encapsulation and release by mesoporous silica nanoparticles: the effect of surface functional groups.
    Tan SY; Ang CY; Li P; Yap QM; Zhao Y
    Chemistry; 2014 Sep; 20(36):11276-82. PubMed ID: 25044108
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multi-stimuli responsive mesoporous carbon nano-platform gated by human serum albumin for cancer thermo-chemotherapy.
    Zhao Q; Wang X; Yang M; Li X; Mao Y; Guan X; Di D; Wang S
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110532. PubMed ID: 31590051
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Selective Cellular Uptake and Druggability Efficacy through Functionalized Chitosan-Conjugated Polyamidoamine (PAMAM) Dendrimers.
    Hu Y; Chen J; Hu W
    Sensors (Basel); 2024 Jul; 24(15):. PubMed ID: 39123900
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Janus Gold Nanoplatform for Synergetic Chemoradiotherapy and Computed Tomography Imaging of Hepatocellular Carcinoma.
    Wang Z; Shao D; Chang Z; Lu M; Wang Y; Yue J; Yang D; Li M; Xu Q; Dong WF
    ACS Nano; 2017 Dec; 11(12):12732-12741. PubMed ID: 29140684
    [TBL] [Abstract][Full Text] [Related]  

  • 72. pH Responsiveness of Hexosomes and Cubosomes for Combined Delivery of
    Li Y; Angelova A; Hu F; Garamus VM; Peng C; Li N; Liu J; Liu D; Zou A
    Langmuir; 2019 Nov; 35(45):14532-14542. PubMed ID: 31635451
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enhanced anti-tumor activity of a drug through pH-triggered release and dual targeting by calcium phosphate-covered mesoporous silica vehicles.
    Liu J; Hu X; Jin S; Liang XJ; Ma X
    J Mater Chem B; 2022 Jan; 10(3):384-395. PubMed ID: 34935843
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficient co-delivery of microRNA 21 inhibitor and doxorubicin to cancer cells using core-shell tecto dendrimers formed via supramolecular host-guest assembly.
    Song C; Xiao Y; Ouyang Z; Shen M; Shi X
    J Mater Chem B; 2020 Apr; 8(14):2768-2774. PubMed ID: 32154812
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application.
    Teng X; Cheng S; Meng R; Zheng S; Yang L; Ma Q; Jiang W; He J
    J Nanosci Nanotechnol; 2015 May; 15(5):3773-9. PubMed ID: 26505004
    [TBL] [Abstract][Full Text] [Related]  

  • 76. pH-Triggered geometrical shape switching of a cationic peptide nanoparticle for cellular uptake and drug delivery.
    Gong Z; Lao J; Gao F; Lin W; Yu T; Zhou B; Dong J; Liu H; Bai J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110811. PubMed ID: 31982793
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stepwise-acid-active organic/inorganic hybrid drug delivery system for cancer therapy.
    Chen H; Chen Z; Kuang Y; Li S; Zhang M; Liu J; Sun Z; Jiang B; Chen X; Li C
    Colloids Surf B Biointerfaces; 2018 Jul; 167():407-414. PubMed ID: 29704741
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deep Tumor Penetration of Drug-Loaded Nanoparticles by Click Reaction-Assisted Immune Cell Targeting Strategy.
    Lee SH; Park OK; Kim J; Shin K; Pack CG; Kim K; Ko G; Lee N; Kwon SH; Hyeon T
    J Am Chem Soc; 2019 Sep; 141(35):13829-13840. PubMed ID: 31382746
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J
    Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
    Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.